In vivo therapeutic effects of affinity-improved-TCR engineered T-cells on HBV-related hepatocellular carcinoma亲和改良TCR工程化T细胞对HBV相关肝癌的体内治疗作用JOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62020-12-1529OAAI
High-affinity human programmed death-1 ligand-1 variant promotes redirected T cells to kill tumor cells (vol 447, pg 164, 2019)CANCER LETTERSIF10.12019-06-010PREAI
High-affinity human programmed death-1 ligand-1 variant promotes redirected T cells to kill tumor cellsCANCER LETTERSIF10.12019-04-019PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向